Drawing for LENTIGLOBIN

USPTO serial 79228010

LENTIGLOBIN

Reviewed by CopyMark Law Group

Reg. 5736038Status 709
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
KEAM, ALEX S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LENTIGLOBIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John L. DuPre'

John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C.155 Seaport Blvd.Boston, MA 01742-9133United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of genetic diseasesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 14, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 18, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 14, 2025C71TCANCELLED SECTION 71—
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 13, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 15, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 23, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 23, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 26, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 18, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 13, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 24, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 24, 2019FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 13, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 9, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2018ALIEASSIGNED TO LIE—
Dec 4, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 8, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 25, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 25, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Sep 25, 2018CNSLSUSPENSION LETTER WRITTEN—
Sep 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2018RFNTREFUSAL PROCESSED BY IB—
Mar 27, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 20, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2018RFRRREFUSAL PROCESSED BY MPU—
Mar 13, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 6, 2018DOCKASSIGNED TO EXAMINER—
Mar 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance